Growth Metrics

Insulet (PODD) Cost Of Revenue (2016 - 2025)

Insulet (PODD) has disclosed Cost of Revenue for 16 consecutive years, with $215.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 29.17% year-over-year to $215.2 million, compared with a TTM value of $768.2 million through Dec 2025, up 22.74%, and an annual FY2025 reading of $768.2 million, up 22.74% over the prior year.
  • Cost of Revenue was $215.2 million for Q4 2025 at Insulet, up from $196.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $215.2 million in Q4 2025 and bottomed at $2.4 million in Q4 2021.
  • Average Cost of Revenue over 5 years is $132.5 million, with a median of $137.2 million recorded in 2023.
  • The sharpest move saw Cost of Revenue plummeted 96.81% in 2021, then surged 2241.67% in 2022.
  • Year by year, Cost of Revenue stood at $2.4 million in 2021, then soared by 2241.67% to $56.2 million in 2022, then surged by 164.41% to $148.6 million in 2023, then rose by 12.11% to $166.6 million in 2024, then grew by 29.17% to $215.2 million in 2025.
  • Business Quant data shows Cost of Revenue for PODD at $215.2 million in Q4 2025, $196.1 million in Q3 2025, and $196.9 million in Q2 2025.